National Center of Regenerative Medicine-Stem Cell Pilot

If this is your first time using WebGrants, you will need to register online at Once you have registered, you will receive an email with your user name and password. The registration process can take up to 24 hours, so applicants are strongly advised to register for an account as soon as possible. Last minute registrations are NOT guaranteed to be approved prior to the deadline. Extensions of the deadline will NOT be given for late registrants.

Available Funds

  • Current funds for this program come from the April 2009 award from the Research Commercialization Program (RCP) of $5 million which includes $200,000 annual funding for pilot projects. Additional funds from the Case Western Reserve University Clinical and Translational Science Collaborative (CTSC) for Core Utilization Pilot Awards will be added to leverage and promote new projects in stem cell translational research.

The National Center of Regenerative Medicine (NCRM) is composed of investigators from Case Western Reserve University (CWRU), University Hospitals Case Medical Center (UHCMC), Cleveland Clinic (CC), Athersys Inc., and Ohio State University. NCRM's mission is to rapidly translate cutting-edge adult-derived stem cell technology into the clinic and commercial arenas. Currently ten different non-embryonic and two pluripotent stem cell types are being investigated in a range of therapeutic areas including cancer, musculoskeletal, orthopedic, cardiovascular, hematopoietic and neurodegenerative disorders.

Applications should be submitted through Webgrants at

For questions:

For questions contact: 
Michael Gilkey at, 216-368-2079